Strategists continued to downgrade their views on the US equity market, with Evercore ISI joining firms in saying it was too optimistic in its 2025 targets. RBC Capital Markets, Goldman Sachs Group Inc., Barclays and Yardeni Research all slashed theirs due to tariff uncertainty.
